- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
FDA approves AiRTouch portable X rays for use during Covid 19 outbreak

The US Food and Drug Administration (FDA) has approved portable X-ray system AiRTouch for human medical use.The device is said to be as simple and efficient frontline tool to obtain chest X-rays for Covid-19 diagnosis.Aspenstate has been granted approval by FDA. AiRTouch was developed by Aspenstate parent company, Livermoretech Korea. This revolutionary device comes equipped with an all-in-one...
The US Food and Drug Administration (FDA) has approved portable X-ray system AiRTouch for human medical use.The device is said to be as simple and efficient frontline tool to obtain chest X-rays for Covid-19 diagnosis.
Aspenstate has been granted approval by FDA. AiRTouch was developed by Aspenstate parent company, Livermoretech Korea. This revolutionary device comes equipped with an all-in-one PC that loads the customer's acquisition software. The advantages of AiRTouch device Include -
Wireless and compact design requires minimal space and accommodations
Minimize radiation to patient and operator with lowest possible dose
Maximize day-to-day efficiency with industry-leading battery performance
Begin operation immediately with seamlessly integrated software solution and built-in workstation
The AiRTouch device has a unique list of capabilities in the battle against COVID-19.The light weight handheld design and high-performance battery of AiRTouch enables screening centres to quickly process high volumes of patients.
In addition to it AiRTouch can acquire images directly to the device and wirelessly transmit to PACS, using the built-in workstation.
This revolutionary device comes equipped with an all-in-one PC that loads the customer's acquisition software. The high-performance battery charges within two hours and can capture up to 300 exposures on a single charge.
AiRTouch's built-in PC also enables remote diagnostics and service and eliminates the need for costly and timely service calls by maximising the uptime of the equipment.
Aspenstate vice-president and COO David Lee said: "Our clients have noticed a dramatic increase in capacity and the ability to move patients through quickly and efficiently. They find that the device is very simple to use, and the integrated software and portable features allow them to work outside of the limitations of traditional X-ray solutions."
Livermoretech Korea, the parent company of Aspenstate, developed the device, which is equipped with an all-in-one PC that loads the customer's acquisition software.
Aspenstate offers complete imaging solutions for X-ray distributors and custom-designed solutions for original equipment manufacturers (OEMs) in the US.
The company noted that the drive-through screening centres in South Korea have benefited from its portability.
Other applications for this device include imaging for urgent care, ambulances, sports medicine, extremities, dental, veterinary and equine purposes.
For further reference log on to:
Aspenstate Inc
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Before Joining Medical Dialogues, he has served at important positions in the medical industry in India including as the Hony. Secretary of the Delhi Medical Association as well as the chairman of Anti-Quackery Committee in Delhi and worked with other Medical Councils in India. Email: editorial@medicaldialogues.in. Contact no. 011-43720751